We have an updated report [Version - 2024] available. Kindly sign up to get the sample of the report.
all report title image

CORDYCEPS SINENSIS AND MILITARIS EXTRACT MARKET ANALYSIS

Cordyceps Sinensis And Militaris Extract Market, by Formulation (Tablet, Liquid, Powder, Extract Powder, Whole Powder), by Application (Medicine, Dietary Supplement, Food Additives), by Strain Type (Cordyceps Sinensis, Cordyceps Militaris), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, And Africa) Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

  • Published In : Oct 2022
  • Code : CMI2578
  • Pages :167
  • Formats :
      Excel and PDF
  • Industry : Pharmaceutical

Regional Analysis

Global Cordyceps Sinensis and Militaris Extract Market – Regional Analysis

On the basis of region, the global Cordyceps Sinensis and Militaris Extract market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.

North America is expected to be the most lucrative region in the global Cordyceps Sinensis and Militaris Extract market, owing to increasing product launches by the market players is expected to foster the regional market growth over the forecast period. For instance, in April 2021, Shroomshot, a company that manufactures organic products and is based in California, U.S., had launched its third functional mushroom blend Inner Energy, which is made with 1,000 mg of freshly harvested and extracted organic cordyceps mushroom fruiting bodies.

Europe is expected to hold a major market share in the global Cordyceps Sinensis and Militaris Extract market, owing to increasing initiatives by market players to develop medicinal products by utilizing key ingredients isolated from cordyceps For instance, in July 2019, NuCana, a U.K.-based clinical-stage biopharmaceutical company focused on significantly improving survival outcomes for patients with cancer, initiated phase 1 clinical study (NUC-7738) on ProTide transformation of cordycepin (NuTide:701 - nucleoside analog) to evaluate its safety and efficiency in the treatment of advanced solid tumors and hematological malignancies.

  • North America: U.S. and Canada
  • Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
  • Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
  • Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
  • Middle East: GCC, Israel, and Rest of Middle East
  • Africa: South Africa, North Africa, and Central Africa

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now
Logo

Credibility and Certifications

ESOMAR
DUNS Registered
Clutch
DMCA Protected

9001:2015

Credibility and Certifications

27001:2022

Credibility and Certifications

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.